2018: Briefing note on NIH proposed license to Gilead for CD-30 CAR T technology

Contact: Kim Treanor 202-332-2670; kim.treanor@keionline.org January 5, 2018 The National Institutes of Health (NIH) has proposed an exclusive license with Gilead for certain patent applications for inventions that target CD-30 proteins and CAR T technologies. The proposed license is to… Continue Reading

Chilean Cámara de Diputados Votes Overwhelmingly To Proceed With Compulsory Licenses for HCV Drugs

The Cámara de Diputados of the Chilean Congress has overwhelmingly passed a resolution calling on the President to advance the compulsory licensing request on HCV drugs made in March 2017 by patients, advocates including Innovarte NGO, and elected officials. The resolution, Number… Continue Reading

Asia Pacific Group asks WIPO to initiate exploratory discussions on the Report of the UN High Level Panel on Access to Medicines

On Monday, 11 December 2017, Indonesia, on behalf of the Asia Pacific Group, delivered the following opening statement at the 27th session of the WIPO Standing Committee on the Law of Patents (SCP). The Asia Pacific Group issued a clarion… Continue Reading